Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Foster-McClellan Company was a historical pharmaceutical firm headquartered in Buffalo, New York, that gained international recognition for its proprietary medicines. Founded in 1898, the company is most famous for the development and global distribution of Doan's Kidney Pills, a popular over-the-counter treatment for backache and urinary tract issues. At its peak, the company maintained a significant global footprint with offices in London, Sydney, and Cape Town, utilizing extensive print advertising to build brand loyalty. The firm specialized in the manufacture of small molecule analgesics and treatments for common ailments. Although the independent company eventually ceased operations, its flagship brands were acquired by larger entities such as CIBA-Geigy, which later merged into Novartis. Today, the legacy of Foster-McClellan persists through the continued commercial availability of the Doan's brand under various consumer health umbrellas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Foster McClellan.